Search results for "Anticoagulation"
Recommended therapies after ischemic stroke less likely to be received by the elderly
GAO to conduct survey on vaccinations under Medicare
https://immattersacp.org/weekly/archives/2010/12/07/6.htm
7 Dec 2010
MKSAP Quiz: evaluation for anticoagulation management
A 32-year-old woman is evaluated for anticoagulation management after an uncomplicated vaginal delivery of a healthy newborn. She was diagnosed with a bilateral pulmonary embolism at 25 weeks' gestation and was treated with therapeutic low-molecular-weight heparin (LMWH). The LMWH was discontinued at the onset of labor and was restarted 6 hours after delivery. Medical history is otherwise unremarkable, and her only medication is full-dose LMWH. Anticoagulation for 3 months is planned. The patient wishes to breastfeed her newborn. What is the most appropriate anticoagulation option for this patient?
https://immattersacp.org/weekly/archives/2016/02/23/3.htm
23 Feb 2016
Benzodiazepines may confer dementia risk for elderly patients
Patients who started taking benzodiazepines after age 65 had a greater risk of developing dementia than those who never used the drugs, a study found.
https://immattersacp.org/weekly/archives/2012/10/02/2.htm
2 Oct 2012
Drug-eluting stents associated with benefits in patients age 85 and older
Drug-eluting stents are being used less often in elderly patients, even though their use is associated with better outcomes in these patients, a new study found.
https://immattersacp.org/weekly/archives/2012/01/10/4.htm
10 Jan 2012
Dabigatran noninferior to warfarin for preventing VTE recurrence
In patients who had a previous venous thromboembolism (VTE), dabigatran prevented recurrence about as well as warfarin and caused fewer bleeding events, according to two new manufacturer-sponsored trials of extended treatment.
https://immattersacp.org/weekly/archives/2013/02/26/5.htm
26 Feb 2013
Warfarin associated with lower stroke, systemic thromboembolism risk in patients with both afib and CKD
The addition of chronic kidney disease (CKD) to atrial fibrillation is associated with an increased risk of stroke or systemic thromboembolism and bleeding. Warfarin treatment was associated with decreasing this risk, a new study found.
https://immattersacp.org/weekly/archives/2012/08/21/6.htm
21 Aug 2012
Statins after stroke not associated with intracerebral hemorrhage
Taking statins following an ischemic stroke was not associated with an increased risk of intracerebral hemorrhage, researchers found.
https://immattersacp.org/weekly/archives/2011/09/20/2.htm
20 Sep 2011
MKSAP Quiz: diagnosing hematologic abnormalities
This week's quiz asks readers to determine appropriate diagnostic testing for a 26-year-old woman admitted to the hospital with deep venous thrombosis.
https://immattersacp.org/weekly/archives/2011/11/15/3.htm
15 Nov 2011
Apixaban associated with more bleeding, no change in ischemic events
A phase 3 trial of apixaban, a new factor Xa inhibitor, was halted after the drug was found to increase major bleeding in patients taking it after acute coronary syndrome.
https://immattersacp.org/weekly/archives/2011/08/02/5.htm
2 Aug 2011
Rivaroxaban noninferior to warfarin for stroke, embolism in atrial fibrillation
Rivaroxaban was noninferior to warfarin for the prevention of stroke or systemic embolism in patients with atrial fibrillation, a study found.
https://immattersacp.org/weekly/archives/2011/08/16/4.htm
16 Aug 2011